荨麻
发表于 2025-3-26 23:12:07
http://reply.papertrans.cn/23/2287/228687/228687_31.png
drusen
发表于 2025-3-27 03:17:45
http://reply.papertrans.cn/23/2287/228687/228687_32.png
glans-penis
发表于 2025-3-27 06:50:33
http://reply.papertrans.cn/23/2287/228687/228687_33.png
Inflated
发表于 2025-3-27 13:01:00
http://reply.papertrans.cn/23/2287/228687/228687_34.png
浮雕
发表于 2025-3-27 16:21:20
Scientific and Other Interests,Current recombinant DNA technology enables the production of pure and safe preparations of coagulation factors destined for the treatment of the bleeding disorder hemophilia.
gentle
发表于 2025-3-27 18:26:37
https://doi.org/10.1057/9780230281981. of platelet concentrates is related to the ability of platelet concentrates (PC) to control or prevent bleeding in thrombocytopenic patients. It has to be separated from quality.
neoplasm
发表于 2025-3-28 00:15:44
Discussion Dr. Hoyer, how does the EGF fit into the four domains which you mentioned in the beginning, the Gla domain, the growth factor domain, the activation peptide domain and the catalytic domain?
verdict
发表于 2025-3-28 04:46:43
Trends in the Production and use of Coagulation Factor ConcentratesThe major concerns today in coagulation factor production and use are virus safety, other aspects of immediate and long-term safety, and the possibility of immune modulation by repeated injection of impure factor VIII.
wreathe
发表于 2025-3-28 06:36:33
Immunoaffinity Purification of Factor VIII/von Willebrand Factor ComplexOver the last 20 years several procedures have been developed for purification of proteins for clinical use. Especially in the 80s chromatography has been developed as one of the main approaches for the purification of coagulation protein factor VIII (FVIII) .
Range-Of-Motion
发表于 2025-3-28 14:17:00
http://reply.papertrans.cn/23/2287/228687/228687_40.png